Analystreport

Nabriva Therapeutics plc (NASDAQ: NBRV) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Nabriva Therapeutics plc - Ordinary Shares  (NBRV) 
Last nabriva therapeutics plc - ordinary shares earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.nabriva.com/investor-relations